[Form 4] Enact Holdings, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Genworth Holdings, Inc. reported the sale of 922,169 shares of Enact Holdings, Inc. (ACT) common stock on 09/30/2025 at a price of $38.3466 per share. The filing states the transaction was effected under a Share Repurchase Agreement dated April 30, 2025, and the per-share price reflects a weighted average price paid by the issuer for third-party purchases under that agreement. After the reported sale, Genworth Holdings beneficially owned 117,951,281 shares, which the filing says represents approximately 81% ownership of Enact outstanding common stock.

Positive

• None.

Negative

• Insider disposition: Genworth sold 922,169 shares of ACT, a sizeable transaction that reduces the parent's stake though it remains a majority holder.

Insights

Financial Analyst

TL;DR Insurer parent executed a substantial disposition under a repurchase agreement; ownership remains majority at ~81%.

The Form 4 documents a non-derivative sale of 922,169 Enact (ACT) shares executed 09/30/2025 at $38.3466 per share under a previously disclosed Share Repurchase Agreement. The reported price is described as a weighted average based on issuer purchases from third parties, indicating the transaction was part of an organized repurchase program rather than an open-market block sale by the parent. Despite the sale, Genworth retains a dominant stake of 117,951,281 shares (~81%), so control and strategic influence remain intact. For investors, this is a liquidity event by the majority holder, not a change in control.

Corporate Governance Expert

TL;DR Majority shareholder sold shares under contract; governance control unchanged but notable insider disposition occurred.

The disclosure clearly ties the sale to a Share Repurchase Agreement dated April 30, 2025, which suggests the transaction follows contractual terms rather than an ad hoc insider transfer. The filing provides the exact number of shares sold, the per-share price methodology, and post-transaction beneficial ownership equal to approximately 81% of outstanding common stock. From a governance perspective, the parent company continues to hold decisive voting power, so this transaction does not materially alter board control or shareholder voting dynamics, though ongoing repurchase activity should be monitored for frequency and size.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Genworth Holdings, Inc.

(Last) (First) (Middle)

11011 WEST BROAD STREET

(Street)

GLEN ALLEN VA 23060

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Enact Holdings, Inc. [ ACT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/30/2025		S(1)		922,169	D	$38.3466(2)	117,951,281	D(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sale reported in this Form 4 was effected pursuant to a Share Repurchase Agreement between Enact Holdings, Inc. (the "Issuer") and Genworth Holdings, Inc. dated as of April 30, 2025 (the "Agreement"). A copy of the Agreement can be found as exhibit 10.1 to the Issuer's Form 10-Q for the quarterly period ended March 31, 2025, on the SEC's website at: https://www.sec.gov/Archives/edgar/data/1823529/000182352925000124/enact-genworthrepurchaseag.htm.

2. Represents a price per share determined pursuant to the terms of the Agreement, based on a weighted average price paid by the Issuer for purchases from third-parties.

3. Genworth Holdings, Inc. owns approximately 81% of the outstanding shares of common stock of the Issuer.

Remarks:

	/s/ Lisa J. Baldyga, Vice President and Treasurer on behalf of Genworth Holdings, Inc.	10/01/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Genworth Holdings report on Form 4 for Enact Holdings (ACT)?

The Form 4 reports a sale of 922,169 shares of Enact common stock on 09/30/2025 at a price of $38.3466 per share.

Was the sale part of an agreement or an open-market trade?

The filing states the sale was effected pursuant to a Share Repurchase Agreement dated April 30, 2025 between Enact and Genworth.

How many Enact shares did Genworth beneficially own after the reported transaction?

After the transaction Genworth beneficially owned 117,951,281 shares, approximately 81% of outstanding common stock.

What does the reported per-share price represent?

The per-share price of $38.3466 is described as a weighted average price determined per the Agreement, based on the issuer's purchases from third parties.

Who signed the Form 4 filing on behalf of Genworth?

The filing was signed by Lisa J. Baldyga, Vice President and Treasurer on behalf of Genworth Holdings, Inc.